CytoSorbents Appoints Daniel Wendt, MD, PhD, MHBA, FECTS as

/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

Related Keywords

Germany , Erlangen , Bayern , United States , West German , Efthymios Deliargyris , Eric Kim , Edwards Lifesciences , Daniel Wendt , Twitter , Material Command , Vascular Center , University Duisburg , Essen University Medical School , European Union , Us Army , Facebook , Blood Institute , Cytosorbents Corporation , National Heart , School Of Business , Master Of Health Business Administration , Essen Medical School In , Us Department Of Health , National Institutes Of Health , Human Services , Us Air , Affairs Cardiovascular , Corporate Communications , Sorbents Corporation , Professor Daniel Wendt , Vice President , Medical Affairs Cardiovascular , Cardiovascular Surgery Clinic , West German Heart , Cardiac Surgery , Essen University Medical , Chief Medical Officer , Medical Degree , University Duisburg Essen Medical School , Full Professor , European Board , Cardiothoracic Surgery , Health Business Administration , Friedrich Alexander University School , Use Authorization , Removal System , Timely Antithrombotic Removal Ticagrelor , Timely Antithrombotic Removal , Oral Anticoagulants , National Institutes , Operations Command , Air Force Material Command , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Relations Contact , Investor Relations ,